Epigenetic discoveries and innovations may advance personalised medicine well beyond the realms of the genome, bringing hope for many people living with life-threatening and debilitating diseases and revealing exciting opportunities for the biopharmaceutical industry. This rapidly evolving area is transforming our understanding of the fundamental biological processes that underpin human disease, development and ageing. Dr Jason Mellad at Cambridge Epigenetix defines how technologies that harness precise and powerful epigenetic mechanisms have the potential to revolutionise approaches to diagnostics and therapeutics on a global scale.

[wonderplugin_pdf src=”https://www.biopharmaceuticalmedia.com/wp-content/uploads/2018/12/Harnessing-the-power-of-epigenetics.pdf” width=”100%” height=”900px” style=”border:0;”]